Showing results (101-110 of 241) with videos related to

Sort By:
Pageof 25
Leukemia|November 10, 2020
Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targetsShady Adnan-Awad, Daehong Kim, Helena Hohtari, et al.
Blood|May 15, 2007
Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 studyOliver Ottmann, Hervé Dombret, Giovanni Martinelli, et al.
Blood|December 19, 2013
Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitorsHagop M Kantarjian, Jorge E Cortes, Dong-Wook Kim, et al.
Cancer Immunology Research|January 12, 2017
Dasatinib Changes Immune Cell Profiles Concomitant with Reduced Tumor Growth in Several Murine Solid Tumor ModelsCan Hekim, Mette Ilander, Jun Yan, et al.
Blood|May 13, 2011
BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNetSimona Soverini, Andreas Hochhaus, Franck E Nicolini, et al.
European Journal of Haematology|July 12, 2005
Expression of cyclin A1 and cell cycle proteins in hematopoietic cells and acute myeloid leukemia and links to patient outcomeJenny Ekberg, Caroline Holm, Sara Jalili, et al.
Genes, Chromosomes & Cancer|March 31, 2007
Fusion gene-mediated truncation of RUNX1 as a potential mechanism underlying disease progression in the 8p11 myeloproliferative syndromeHelena Agerstam, Henrik Lilljebjörn, Carin Lassen, et al.
British Journal of Haematology|August 30, 2002
Intensive chemotherapy in patients with chronic myelogenous leukaemia (CML) in accelerated or blastic phase--a report from the Swedish CML GroupUlla Axdorph, Leif Stenke, Gunnar Grimfors, et al.
Plos One|July 7, 2025
Quantitative MRI relaxometry in brain tumor needle biopsies: Multimodal comparison with tissue fluorescence, radiology, and neuropathologyElisabeth Klint, Anders Tisell, Ida Blystad, et al.
Leukemia|August 13, 2020
RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responsesShady Adnan Awad, Olli Dufva, Aleksandr Ianevski, et al.
Pageof 25